Abstract
Identification of the molecular lesion in Caenorhabditis elegans mutants isolated through forward genetic screens usually involves time-consuming genetic mapping. We used Illumina deep sequencing technology to sequence a complete, mutant C. elegans genome and thus pinpointed a single-nucleotide mutation in the genome that affects a neuronal cell fate decision. This constitutes a proof-of-principle for using whole-genome sequencing to analyze C. elegans mutants.
Original language | English (US) |
---|---|
Pages (from-to) | 865-867 |
Number of pages | 3 |
Journal | Nature Methods |
Volume | 5 |
Issue number | 10 |
DOIs | |
State | Published - 2008 |